Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases

- April 25th, 2018

Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a collaboration agreement with LumiraDx to develop new POC diagnostic tests for infectious diseases. Under terms of the agreement, Chembio will receive funding from LumiraDx, subject to satisfying certain milestones, to develop certain new POC infectious disease … Continued

Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a collaboration agreement with LumiraDx to develop new POC diagnostic tests for infectious diseases. Under terms of the agreement, Chembio will receive funding from LumiraDx, subject to satisfying certain milestones, to develop certain new POC infectious disease tests.

As quoted in the press release:

“We selected Chembio as our partner due to the company’s expertise in developing high-quality POC infectious disease assays, and we believe the commercial opportunity for both firms is significant,” stated Ron Zwanziger, LumiraDx’s Chairman and Chief Executive Officer.

The LumiraDx collaboration enables Chembio to further pursue its strategy through the development of a portfolio of new POC infectious disease tests that utilize Chembio’s scientific expertise in the field of POC infectious disease.

“We are excited about the collaboration with LumiraDx as it validates our scientific expertise and complements our DPP® platform strategy,” stated John Sperzel, Chembio’s Chief Executive Officer. “Through our joint efforts, we expect the new products to provide access to a broader customer base. In addition, we anticipate expanding our product portfolio by applying reagent biomarkers funded through this agreement to our DPP® platform.”

Click here to read the full press release.

3 responses to “Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases

  1. Trust the Government to do everything half-assed. Packaging is all part of the retail experience with EVERYTHING and keeps manufacturers on their toes.. SOOOO lets all just go buy a car (no idea what the brand is, as the manufacturer cant show their brands) but they all have the necessary items in order for you to drive it away. GEES I really like that car and I would buy another or refer it to a friend BUT since its not branded I don’t know who make the friggin thing. If it breaks, so what ,nobody knows who made it so what parts to use ???? The idea here is identify your products and make them memorable and then all will be monitored by the buying public and should I also say the government as well. Okay plain packaging isn’t enticing to any one so do you think the kids give a rip who makes it anyway, probably NOT they will buy it anyway. Identifying the products and everything that would entail should be mandatory. When kids grow up they then probably would be more aware of packaging and branding and could use that to their advantage, but to say NOT to brand will entice kids I think is a flawed idea. But then the government is a flawed part of our society anyway so what can we expect. ABSOLUTELY NOTHING.

Leave a Reply

Your email address will not be published. Required fields are marked *